Optovue Supplement: OCT Angiography: The Newest Frontier for the Revolutionary Technology
The AngioVue Difference
Optovue has developed a new way of visualizing vessels that allows clinicians to identify retinal circulation using the intrinsic motion of the bloodcells in the vessel with non-invasive microvascular enhanced imaging. These devices use optical coherence tomography-angiography (OCT-A), and are by far the most advanced imaging products to date.
The AngioVue Imaging System is not like traditional OCT. It acquires function rather than structural information. This system is also very different from traditional angiography such as fluorescein angiography or ICAG since it does not require contrast dye injection that can be difficult to accomplish on some patients. Download Supplement - click here
Latest Articles
From Lab to Life: Corneal Repair Goes Cellular
Long-awaited cellular therapies for corneal endothelial disease enter the clinic.
Balancing Innovation and Safety
Ensuring access to advanced cell therapies amid regulatory overhaul.
With Eyes on Its Future, ESCRS Celebrates Its Past
Winter Meeting offers opportunities to experiment with new concepts and formats.
Best of ESCRS Winter Meeting 2024
Following the New Generation
EDOF IOLs an option for eyes with mild comorbidities, showing potential in mini-monovision strategies.
Refocus on Multifocals
Trifocal IOLs continue to improve as consensus grows regarding indications and contraindications.
Common Myths in Presbyopia Correction
Patient education key to satisfaction with refractive IOLs.
Reversible Multifocality
Two-lens combination offers low-risk spectacle independence for cataract patients and presbyopes.
Managing a Cataract Surgery Refractive Miss
Weighing the pros and cons of options for intraocular intervention.
Unleashing OCT’s Full Potential
Performance of newest tool for corneal evaluation meets or beats older standard technologies.